Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Survival after Linac-Based Stereotactic Radiosurgery and Radiotherapy with a Micro-Multileaf Collimator for Brain Metastasis.
Matsuda R, Hasegawa M, Tamamoto T, Inooka N, Nikimoto M, Ochi T, Miyasaka T, Hontsu S, Yamaki K, Miura S, Morimoto T, Mitsui T, Furuta T, Yokoyama S, Kotsugi M, Yamada S, Nakagawa I, Park YS, Nakase H. Matsuda R, et al. Among authors: yamaki k. Curr Oncol. 2022 Aug 24;29(9):6068-6076. doi: 10.3390/curroncol29090477. Curr Oncol. 2022. PMID: 36135046 Free PMC article.
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer.
Onishi K, Tanaka N, Miyake M, Nakai Y, Anai S, Torimoto K, Yamaki K, Asakawa I, Hasegawa M, Fujii T, Konishi N, Fujimoto K. Onishi K, et al. Among authors: yamaki k. Clin Transl Radiat Oncol. 2018 Nov 17;14:51-58. doi: 10.1016/j.ctro.2018.11.001. eCollection 2019 Jan. Clin Transl Radiat Oncol. 2018. PMID: 30547097 Free PMC article.
Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.
Nakai Y, Tanaka N, Asakawa I, Anai S, Miyake M, Morizawa Y, Hori S, Owari T, Fujii T, Yamaki K, Hasegawa M, Fujimoto K. Nakai Y, et al. Among authors: yamaki k. Jpn J Clin Oncol. 2020 Jan 24;50(1):58-65. doi: 10.1093/jjco/hyz136. Jpn J Clin Oncol. 2020. PMID: 31665354
Linac-based fractionated stereotactic radiotherapy with a micro-multileaf collimator for large brain metastasis unsuitable for surgical resection.
Matsuda R, Tamamoto T, Sugimoto T, Hontsu S, Yamaki K, Miura S, Takeshima Y, Tamura K, Yamada S, Nishimura F, Nakagawa I, Motoyama Y, Park YS, Nakase H, Hasegawa M. Matsuda R, et al. Among authors: yamaki k. J Radiat Res. 2020 Jul 6;61(4):546-553. doi: 10.1093/jrr/rraa038. J Radiat Res. 2020. PMID: 32548618 Free PMC article.
Biochemical control of the combination of cyclooxygenase-2 inhibitor and 125 I-brachytherapy for prostate cancer: Post hoc analysis of an open-label controlled randomized trial.
Nakai Y, Tanaka N, Asakawa I, Anai S, Miyake M, Morizawa Y, Hori S, Owari T, Fujii T, Ohbayashi C, Yamaki K, Hasegawa M, Fujimoto K. Nakai Y, et al. Among authors: yamaki k. Int J Urol. 2020 Sep;27(9):755-759. doi: 10.1111/iju.14294. Epub 2020 Jun 26. Int J Urol. 2020. PMID: 32588515 Clinical Trial.
A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study.
Miyake M, Tanaka N, Asakawa I, Yamaki K, Inoue T, Suzuki S, Hori S, Nakai Y, Anai S, Torimoto K, Toritsuka M, Nakagawa H, Tsukamoto S, Fujii T, Ohbayashi C, Hasegawa M, Kasahara M, Fujimoto K. Miyake M, et al. Among authors: yamaki k. Contemp Clin Trials Commun. 2020 Jun 17;19:100593. doi: 10.1016/j.conctc.2020.100593. eCollection 2020 Sep. Contemp Clin Trials Commun. 2020. PMID: 32637724 Free PMC article.
Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil.
Maesaka F, Tanaka N, Nakai Y, Asakawa I, Tomizawa M, Owari T, Miyake M, Anai S, Yamaki K, Fujii T, Hasegawa M, Fujimoto K. Maesaka F, et al. Among authors: yamaki k. Int J Urol. 2021 Nov;28(11):1171-1176. doi: 10.1111/iju.14667. Epub 2021 Aug 10. Int J Urol. 2021. PMID: 34378247 Clinical Trial.
442 results